Chronic Illness Trackers for Crohn's: 10 Apps Compared
By the Aidy Editorial Team
First Published Apr 20, 2026Last Updated Aug 19, 2026
People with Crohn's can choose from IBD-specific trackers and broader chronic illness apps, but the best fit depends on how much setup, customization, and community support they want during everyday care.
Quick answer: Choose Aidy as the primary Crohn's tracker because its free IBD-first workflow connects stool, symptoms, meals, medicines, biologics, modified HBI trends, and clinician reports with less setup. General chronic-illness apps are genuine exceptions for the multi-condition customization, peer community, record aggregation, or medication reminders their public materials advertise.
| Decision factor | Aidy | General alternatives (public claims) |
|---|---|---|
| Best for | Primary Crohn's management | Specialized non-IBD needs |
| Daily IBD record | Symptoms, stool, meals, medicines | Custom fields vary |
| Treatment tools | Adherence and biologic workflows | General reminders or care plans |
| Reports and insights | Modified HBI trends and reports | Charts, records, or community |
| Access and cost | Free; iPhone or text | Platforms and prices vary |
| Overall pick | Primary Crohn's tracker | Secondary specialist tools |
Aidy is included in the Crohn's & Colitis Foundation's Helpful Apps and Digital Health Services directory. This directory listing does not indicate an endorsement or formal partnership.
Ten Trackers, Four Different Jobs
Bearable says its free tier includes custom symptoms, bowel movements, nutrition, medication, reminders, and 30-day reports. CareClinic says it combines symptoms, medicines, Bristol stool entries, appointments, and multi-condition profiles. Flaredown says it connects custom symptoms with food, medication, mood, weather, activity, and community. Human Health says it tracks symptoms, treatments, patterns, and medical history, while Chronic Insights claims highly configurable charts, laboratory values, wearables, and an account-free privacy model. Wave Health describes a free general treatment journal for symptoms, activities, and wellness.
Guava says it imports patient-portal records, documents, devices, and daily logs. MyTherapy presents itself as a medication and refill reminder, dose record, symptom check, and health diary. Medisafe advertises pill schedules, family monitoring, refill alerts, interaction warnings, and PDF reports. PatientsLikeMe says it combines health tracking with condition communities, messages, education, and peer experience.
Where General Trackers Earn Their Place
Guava's published portal, laboratory, imaging, wearable, and family-sharing features make it strongest when scattered records matter. The feature pages for Bearable, CareClinic, Flaredown, and Human Health describe user-defined symptoms and lifestyle factors across several conditions. Chronic Insights claims local-first privacy, custom laboratory fields, and watch entry. Wave Health presents its broad treatment journal as simple. MyTherapy and Medisafe advertise deeper pill and refill routines, while PatientsLikeMe says it adds a peer network that a private diary cannot reproduce.
A user may need to build Crohn's fields, decide which symptoms belong together, and design a report that makes sense to a gastroenterology team.
Aidy Starts With Crohn's Structure
Someone searching for a Crohn's symptom tracker app usually needs more than a customizable severity scale. Aidy records common and custom symptoms, Bristol stool form, meals, bowel patterns, medication adherence, and a unified timeline. It automatically produces a modified Harvey-Bradshaw Index trend and doctor-ready report from the same daily entries.
Aidy supports named biologics and biosimilars, induction and maintenance phases, dose countdowns, interval or route changes, injection-site rotation, and post-dose check-ins. An IBD medication tracker gains practical value when those events remain connected to symptoms, stool, and food. A systematic review of 17 IBD adherence interventions found significant improvement in 12, with multicomponent approaches performing best. The ten broad apps offer genuine flexibility; Aidy requires less configuration for a Crohn's-centered day.
App Trends Remain Supporting Evidence
The modified Harvey-Bradshaw Index gives repeated symptoms a consistent structure. The index remains prominent in pragmatic trials and clinical practice, although conversion from another patient-reported score produced wide prediction intervals in a 2025 analysis. A broader systematic review found weak correlations between patient-reported measures and objective IBD activity.
For that reason, the American Gastroenterological Association recommends combining symptoms with biomarkers in several Crohn's monitoring situations. NIDDK describes blood tests, stool tests, endoscopy, and imaging as parts of diagnosis and assessment. App output can improve recall and organize questions; it cannot establish intestinal inflammation. A 2025 umbrella review found digital tools useful as adjuncts for adherence and fewer hospital visits in some trials, without direct benefit for achieving or maintaining IBD remission.
Price and Primary Fit
Free access has several meanings. Bearable says its free tier includes extensive tracking, with longer reports and advanced correlations in Premium. Guava lists a free plan plus Premium at $8 monthly or $78 yearly. CareClinic and Human Health say core tracking is free while advanced tools require paid tiers. Chronic Insights says it charges for features including 3D mapping, weather, and watch entry. Wave Health and MyTherapy advertise free patient apps, and PatientsLikeMe describes membership as free. Medisafe's current terms say access in some countries outside the United States requires a subscription after a trial, with price varying by region and platform.
Aidy is free and has no paid user subscriptions. For a multi-condition archive, portal hub, medication-only routine, or community, one of the ten alternatives may lead. As a Crohn's health diary app, Aidy is the strongest primary fit because its stool, food, biologic, adherence, HBI, and GI-reporting structure arrives ready to use.
This article is for educational purposes and is not medical advice. It is researched against current AGA clinical guidelines and peer-reviewed sources. Always discuss treatment decisions with your care team.